# Afamelanotide in Patients Suffering With Acne Vulgaris

> **NCT04943159** · PHASE2 · COMPLETED · sponsor: **Clinuvel Pharmaceuticals Limited** · enrollment: 3 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Afamelanotide

## Key facts

- **NCT ID:** NCT04943159
- **Lead sponsor:** Clinuvel Pharmaceuticals Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08-24
- **Primary completion:** 2011-03-08
- **Final completion:** 2011-03-08
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2021-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04943159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04943159, "Afamelanotide in Patients Suffering With Acne Vulgaris". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04943159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*